JP2001520886A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001520886A5 JP2001520886A5 JP2000518092A JP2000518092A JP2001520886A5 JP 2001520886 A5 JP2001520886 A5 JP 2001520886A5 JP 2000518092 A JP2000518092 A JP 2000518092A JP 2000518092 A JP2000518092 A JP 2000518092A JP 2001520886 A5 JP2001520886 A5 JP 2001520886A5
- Authority
- JP
- Japan
- Prior art keywords
- dna
- protein
- amino acid
- acid consensus
- diagnostically
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108020004414 DNA Proteins 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 5
- 108091035707 Consensus sequence Proteins 0.000 description 3
- 230000004156 Wnt signaling pathway Effects 0.000 description 2
- 239000013613 expression plasmid Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 102000013814 Wnt Human genes 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19747418.7 | 1997-10-27 | ||
| DE19747418A DE19747418C1 (de) | 1997-10-27 | 1997-10-27 | Inhibitor-Protein des wnt-Signalwegs |
| PCT/DE1998/003155 WO1999022000A1 (de) | 1997-10-27 | 1998-10-27 | Inhibitor-protein des wnt-signalwegs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001520886A JP2001520886A (ja) | 2001-11-06 |
| JP2001520886A5 true JP2001520886A5 (enExample) | 2005-12-22 |
Family
ID=7846765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000518092A Pending JP2001520886A (ja) | 1997-10-27 | 1998-10-27 | ｗｎｔシグナル経路の阻害タンパク質 |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US6844422B1 (enExample) |
| EP (2) | EP1923465A1 (enExample) |
| JP (1) | JP2001520886A (enExample) |
| AT (1) | ATE391782T1 (enExample) |
| DE (2) | DE19747418C1 (enExample) |
| DK (1) | DK1027440T3 (enExample) |
| ES (1) | ES2306483T5 (enExample) |
| PT (1) | PT1027440E (enExample) |
| WO (1) | WO1999022000A1 (enExample) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7057017B2 (en) * | 1997-04-16 | 2006-06-06 | Millennium Pharmaceuticals, Inc. | Human dickkopf-related protein and nucleic acid molecules and uses therefor |
| ATE505543T1 (de) * | 1997-04-16 | 2011-04-15 | Millennium Pharm Inc | Zusammensetzung, umfassend einen antikörper, der selektiv an ein cysteinreiches sekretiertes protein (crsp) bindet |
| DE19747418C1 (de) | 1997-10-27 | 1999-07-15 | Deutsches Krebsforsch | Inhibitor-Protein des wnt-Signalwegs |
| US7446181B2 (en) | 1998-01-15 | 2008-11-04 | Millennium Pharmaceuticals, Inc. | Antibodies that bind human Dickkopf-1 proteins |
| US6344541B1 (en) | 1998-09-25 | 2002-02-05 | Amgen Inc. | DKR polypeptides |
| WO2000052047A2 (en) * | 1999-03-05 | 2000-09-08 | Millennium Pharmaceuticals, Inc. | Human dickkopf-related protein and nucleic acid molecules and uses therefor |
| AU780358B2 (en) * | 1999-06-08 | 2005-03-17 | Lorantis Limited | Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway |
| EP1224471B1 (en) * | 2000-02-24 | 2003-11-26 | Oxford GlycoSciences (UK) Limited | Dpi-6, a therapeutic biomarker in neurological disorders |
| EP1222933A1 (en) * | 2001-01-15 | 2002-07-17 | Academisch Ziekenhuis Leiden h.o.d.n., Leids Universitair Medisch Centrum | Generation and/or reduction of new lung tissue in an affected lung, by modulation of the Wnt-pathway |
| US7736654B2 (en) | 2001-04-10 | 2010-06-15 | Agensys, Inc. | Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| US7927597B2 (en) | 2001-04-10 | 2011-04-19 | Agensys, Inc. | Methods to inhibit cell growth |
| US7713526B2 (en) * | 2001-05-01 | 2010-05-11 | The Regents Of The University Of California | Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas |
| US20040038860A1 (en) | 2002-05-17 | 2004-02-26 | Allen Kristina M. | Reagents and methods for modulating dkk-mediated interactions |
| IL149404A0 (en) * | 2002-04-29 | 2002-11-10 | Yissum Res Dev Co | METHODS AND COMPOSITIONS FOR MODULATING β-CATENIN PHOSPHORYLATION |
| CA2501235A1 (en) * | 2002-10-04 | 2004-04-22 | The Regents Of The University Of California | Methods for treating cancer by inhibiting wnt signaling |
| US8637506B2 (en) * | 2003-09-22 | 2014-01-28 | Enzo Biochem, Inc. | Compositions and methods for bone formation and remodeling |
| US8367822B2 (en) | 2003-09-22 | 2013-02-05 | Enzo Therapeutics, Inc. | Compositions and methods for bone formation and remodeling |
| US9046537B2 (en) | 2003-09-22 | 2015-06-02 | Enzo Biochem, Inc. | Method for treating inflammation by administering a compound which binds LDL-receptor-related protein (LRP) ligand binding domain |
| US8461155B2 (en) * | 2003-09-22 | 2013-06-11 | University Of Connecticut | Sclerostin and the inhibition of WNT signaling and bone formation |
| WO2005049640A2 (en) | 2003-11-17 | 2005-06-02 | Merck & Co., Inc. | Rhesus monkey dickkopf-1, nucleotides encoding same, and uses thereof |
| US7473770B2 (en) | 2003-11-17 | 2009-01-06 | Merck & Co., Inc. | Cynomolgus monkey dickkopf-4, nucleotides encoding same, and uses thereof |
| WO2005095448A2 (en) * | 2004-03-23 | 2005-10-13 | Oscient Pharmaceuticals Corporation | Method of synthesizing and purifying dkk proteins and dkk proteins obtained thereby |
| EP1753880A4 (en) * | 2004-05-14 | 2010-07-14 | Univ California | METHOD FOR THE TREATMENT OF CANCER USING MONOCLONAL ANTI-WNT2 ANTIBODIES AND siRNA |
| US9052324B2 (en) | 2004-05-19 | 2015-06-09 | Enzo Biochem, Inc. | Compounds and assays for controlling Wnt activity |
| US8343922B2 (en) * | 2004-05-19 | 2013-01-01 | Enzo Biochem, Inc. | Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells |
| AU2005245021A1 (en) | 2004-05-21 | 2005-12-01 | The Regents Of The University Of California | Methods for treating and diagnosing cancer with wnt inhibitory factor-1 (wif-1) |
| ES2414460T3 (es) * | 2004-08-04 | 2013-07-19 | Amgen Inc. | Anticuerpos para Dkk-1 |
| RU2392961C2 (ru) * | 2004-11-10 | 2010-06-27 | Хубрехт Лабораториум | Лечение аденомы и/или аденокарциномы кишечника с помощью ингибирования активации пути notch |
| EP1827470A2 (en) * | 2004-12-09 | 2007-09-05 | Neuro Therapeutics AB | Materials and methods related to dickkopfs (dkk) and neurogenesis |
| EP1795198A1 (en) * | 2005-12-09 | 2007-06-13 | Hubrecht Laboratorium | Treatment of Barret's esophagus |
| AR060017A1 (es) | 2006-01-13 | 2008-05-21 | Novartis Ag | Composiciones y metodos de uso para anticuerpos de dickkopf -1 |
| EP2121755A1 (en) * | 2007-02-08 | 2009-11-25 | Merck & Co., Inc. | Antibodies specific for dkk-1 |
| US20090074668A1 (en) * | 2007-09-14 | 2009-03-19 | Farjo Rafal A | Vldlr-/- mouse models and related methods |
| AR075989A1 (es) | 2009-04-10 | 2011-05-11 | Lilly Co Eli | Anticuerpo dkk -1 (dickkopf-1) humano disenado por ingenieria |
| US20120165270A1 (en) * | 2009-04-27 | 2012-06-28 | Yeon Sook Choi | Inhibition of hair follicle growth by the wnt inhibitor dkk1 |
| PE20120475A1 (es) | 2009-05-12 | 2012-05-05 | Pfizer | Anticuerpos especificos para dkk-1 |
| JP2014509588A (ja) | 2011-03-01 | 2014-04-21 | アムジエン・インコーポレーテツド | 二特異性結合剤 |
| CA2828753C (en) | 2011-03-16 | 2022-07-26 | arGEN-X BV | Antibodies to cd70 |
| WO2013155447A1 (en) * | 2012-04-13 | 2013-10-17 | Children's Medical Center Corporation | Tiki inhibitors |
| UY35148A (es) | 2012-11-21 | 2014-05-30 | Amgen Inc | Immunoglobulinas heterodiméricas |
| US10391168B1 (en) | 2014-08-22 | 2019-08-27 | University Of Bern | Anti-CD70 combination therapy |
| GB201800649D0 (en) | 2018-01-16 | 2018-02-28 | Argenx Bvba | CD70 Combination Therapy |
| TWI848030B (zh) | 2018-12-18 | 2024-07-11 | 比利時商阿根思公司 | Ｃｄ７０組合治療 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6133232A (en) * | 1996-06-20 | 2000-10-17 | The Regents Of The University Of California | Endoderm, cardiac and neural inducing factors |
| AU5613498A (en) | 1996-12-20 | 1998-07-17 | Human Genome Sciences, Inc. | Cerebellum and embryo specific protein |
| ATE505543T1 (de) * | 1997-04-16 | 2011-04-15 | Millennium Pharm Inc | Zusammensetzung, umfassend einen antikörper, der selektiv an ein cysteinreiches sekretiertes protein (crsp) bindet |
| US7057017B2 (en) | 1997-04-16 | 2006-06-06 | Millennium Pharmaceuticals, Inc. | Human dickkopf-related protein and nucleic acid molecules and uses therefor |
| DE19747418C1 (de) | 1997-10-27 | 1999-07-15 | Deutsches Krebsforsch | Inhibitor-Protein des wnt-Signalwegs |
| US7446181B2 (en) | 1998-01-15 | 2008-11-04 | Millennium Pharmaceuticals, Inc. | Antibodies that bind human Dickkopf-1 proteins |
-
1997
- 1997-10-27 DE DE19747418A patent/DE19747418C1/de not_active Expired - Fee Related
-
1998
- 1998-10-27 PT PT98959767T patent/PT1027440E/pt unknown
- 1998-10-27 EP EP08002377A patent/EP1923465A1/de not_active Withdrawn
- 1998-10-27 DK DK98959767T patent/DK1027440T3/da active
- 1998-10-27 ES ES98959767T patent/ES2306483T5/es not_active Expired - Lifetime
- 1998-10-27 WO PCT/DE1998/003155 patent/WO1999022000A1/de not_active Ceased
- 1998-10-27 US US09/530,219 patent/US6844422B1/en not_active Expired - Fee Related
- 1998-10-27 DE DE59814214T patent/DE59814214D1/de not_active Expired - Lifetime
- 1998-10-27 AT AT98959767T patent/ATE391782T1/de active
- 1998-10-27 EP EP98959767A patent/EP1027440B2/de not_active Expired - Lifetime
- 1998-10-27 JP JP2000518092A patent/JP2001520886A/ja active Pending
-
2004
- 2004-10-06 US US10/960,235 patent/US7138508B2/en not_active Expired - Fee Related
-
2006
- 2006-11-20 US US11/561,826 patent/US8536311B2/en not_active Expired - Fee Related
-
2011
- 2011-01-19 US US12/930,858 patent/US8461309B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001520886A5 (enExample) | ||
| Collett et al. | Bovine viral diarrhea virus genomic organization | |
| DK171727B1 (da) | Rekombinante hepatitis B virus DNA-molekyler, værtsorganismer transformeret hermed, HBV-antigenspecifikke polypeptider, DNA-sekvenser kodende for HBV-antigenspecifikke polypeptider, metoder til påvisning af hepatitis B virus-antistoffer, metoder til fremstilling af nævnte DNA-molekyler, fremgangsmåder til fremstilling af nævnte polypeptider og midler til påvisning af HBV-infektion | |
| FI88175C (fi) | Rekombinant-dna-molekyler och foerfaranden foer framstaellning av polypeptider liknande humant -interferon | |
| JPH09322781A5 (enExample) | ||
| CA2196555A1 (en) | Vr-2332 viral nucleotide sequence and methods of use | |
| JP2004511201A5 (enExample) | ||
| NZ505880A (en) | IL-18 receptor polypeptides | |
| AU656159B2 (en) | Cloning and expression of borrelia lipoproteins | |
| JP2002510494A5 (enExample) | ||
| JP2004524824A5 (enExample) | ||
| WO2001066597A3 (en) | Inflammation-related gene | |
| ATE358724T1 (de) | Expression regulierende sequenzen vom schimmelpilz chrysosporium | |
| CA2216741A1 (en) | A novel protein and process for preparing the same | |
| CA2441327A1 (en) | Human arginine-rich protein-related compositions | |
| JP2002517193A5 (enExample) | ||
| KR870000501B1 (ko) | 사람의 프로인슐린의 아미노산 배열을 함유하는 단백질의 제조방법 | |
| CA2138999A1 (en) | Cloning and expression of gonadotropin-releasing hormone receptor | |
| WO2001046394A3 (en) | Mammalian protein phosphatases | |
| ATE280232T1 (de) | Nukleotidsequenzen, welche für das dapf-gen kodieren | |
| WO2003050236A3 (en) | Human genes and gene expression products isolated from human prostate | |
| AU704594B2 (en) | Production of recombinant peptides as natural hydrophobic peptide analogues | |
| WO1996021020A3 (en) | Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases | |
| WO2002068662A8 (en) | Plasmid originated from bifidobacterium, recombinant expression vector using the plasmid and transformation method | |
| WO1989005857A1 (en) | A METHOD OF SIMULTANEOUSLY PRODUCING A LARGE NUMBER OF Leu17-VIP-ANALOGS AND NEW Leu17-VIP-ANALOGS |